DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency
The DOI matches its Crossref record.
Abstract
Modulation of melanogenesis in the melanocytes can be achieved using chemicals that share structural homologies with the substrate tyrosine and as thus competitively inhibit the catalytic function of tyrosinase. We have developed a new tyrosinase inhibitor, deoxyArbutin (dA), based on this premise. DeoxyArbutin demonstrates effective inhibition of mushroom tyrosinase in vitro with a Ki that is 10‐fold lower that hydroquinone (HQ) and 350‐fold lower than arbutin. In a hairless, pigmented guinea pig model, dA demonstrated rapid and sustained skin lightening that was completely reversible within 8 weeks after halt in topical application. In contrast, HQ induced a short but unsustained skin lightening effect whereas kojic acid and arbutin exhibit no skin lightening effect. Results from a panel of safety tests supported the overall establishment of dA as an actionable molecule. In a human clinical trial, topical treatment of dA for 12 weeks resulted in a significant or slight reduction in overall skin lightness and improvement of solar lentigines in a population of light skin or dark skin individuals, respectively. These data demonstrate that dA has potential tyrosinase inhibitory activity that can result in skin lightening and may be used to ameliorate hyperpigmentary lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A comprehensive review on tyrosinase inhibitors
Zolghadri, S., Bahrami, A., Hassan Khan, M. T., Munoz-Munoz, J., Garcia-Molina, F., Garcia-Canovas, F., & Saboury, A. A. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1545767 · Cited by 1,078
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696
The melanogenesis and mechanisms of skin‐lightening agents – existing and new approaches
Gillbro, J. M., & Olsson, M. J. (2011) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00616.x · Cited by 407
Draelos, Z. D. (2007) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2007.00144.x · Cited by 390
Melasma: A comprehensive update
Sheth, V. M., & Pandya, A. G. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.046 · Cited by 377
Metadata
- Authors
- Boissy, R. E., Visscher, M., & DeLong, M. A.
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2005-07-13
- Volume
- 14
- Issue
- 8
- Pages
- 601-608
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2041215732
- Cited by
- 155
- References
- 0
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. https://app.cochat.ai/papers/10.1111/j.0906-6705.2005.00337.x
- The paper
- Boissy, R. E., Visscher, M., & DeLong, M. A. (2005). DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Experimental Dermatology. https://doi.org/10.1111/j.0906-6705.2005.00337.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.